Market Cap (In USD)
863.55 Million
Revenue (In USD)
103.19 Million
Net Income (In USD)
5.26 Million
Avg. Volume
1758.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.513-1.8
- PE
- -
- EPS
- -
- Beta Value
- 1.719
- ISIN
- AU000000PNV0
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Swami Raote BPHARM, M.B.A.
- Employee Count
- -
- Website
- https://polynovo.com
- Ipo Date
- 2021-01-08
- Details
- PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
More Stocks
-
ULGXUrologix, Inc.
ULGX
-
CORE-B
-
GVFG
-
POLSONPolson Limited
POLSON
-
MINESTMinesto AB (publ)
MINEST
-
HENGF
-
6933
-
WWPW